Explainer Episode 65 - Reviewing Michael Cannon's Book "Recovery"
RTP's Fourth Branch Podcast
| Topics: | Administrative Law & Regulation • Healthcare • Regulatory Transparency Project |
|---|---|
| Sponsors: | Regulatory Transparency Project |
In this RTP explainer episode 65, we are joined by Michael Cannon, Director of Health Policy Studies at the Cato Institute, and Christina Sandefur, Executive Vice President of the Goldwater Institute to discuss Michael Cannon’s new book, Recovery.
Listen in as these experts consider the role of government agencies like the FDA in health spaces across America. "Recovery" discusses treatments approved by the FDA and the implications of approved drugs entering the market. Americans are inadvertently affected by the decisions of government agencies. With this said, "Recovery" argues the FDA takes away people’s rights to make their own health decisions. Does the FDA prohibit safe and effective drugs from entering the market? In this episode, experts discuss the implications of the decisions made by the FDA and the consequences of unsafe access to drugs.
Copies of Michael Cannon’s book can be found at, https://www.cato.org/books/recovery
*******
As always, the Federalist Society takes no position on particular legal or public policy issues; all expressions of opinion are those of the speaker.